this mini video course, I want to walk you through our new website and show you what the ecosystem has

February 2022 " Ermium Therapeutics Announces the Formation of a Scientific Advisory Board comprising international leaders in GPCRs pharmacology, immunology, drug discovery and development for auto-immune diseases" Read more at the source #DrGPCR #GPCR #IndustryNews

January 2022 "We are an experienced, innovative, global team on a bold mission to improve health by creating and developing life-changing medicines for people around the world." Read more at the source #DrGPCR #GPCR #IndustryNews

March 2022 ERNEST has established an Emergency Fund for Ukrainian researchers. SCIENTIFIC MISSIONS (STSM) We offer short-term scientific mission grants to Ukrainian researchers who have Our scientific perspective is broad, and we are happy to consider any research proposals from those in

neutrophil chemotaxis. " Authors Xuehua Xu , Xi Wen , Smit Bhimani , Amer Moosa , Dustin Parsons , HyunGee Ha , Tian Ji .

Randy Hall About Dr. Over the past two decades, his lab has published numerous groundbreaking findings shedding light on the Most recently, his lab has made a number of seminal contributions to understanding the signaling, regulation Randy’s lab has a special interest in studying disease-associated mutations to human GPCRs that perturb Randy has received a number of research prizes, including the PhRMA New Investigator Award, the Distinguished

Oliver Hartley About Dr. Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . Since then Oliver has worked at the University of Geneva, where his research on peptide engineering and GPCR pharmacology has led to a series of high-profile publications and new intellectual property, and Oliver Hartley on the web LinkedIn Orion Biotechnology Dr.